文献速递主动脉外科

马凡综合征晚期诊断与未计划主动脉手术及心血管死亡相关

Late diagnosis of Marfan syndrome is associated with unplanned aortic surgery and cardiovascular death.
PubMed 文献 · J Thorac Cardiovasc Surg · 2024-09-19

该回顾性观察性队列研究纳入288例马凡综合征(MFS)患者,评估诊断年龄与治疗起始对延迟升主动脉置换(RAA)和死亡的影响。随访25±14.7年,晚期诊断(≥21岁)是延迟RAA(HR 8.01)和死亡(HR 4.68)的预测因素,而早期OPT未显示关联。

要点

  • 晚期诊断(≥21岁)与延迟RAA风险升高相关(HR 8.01)。
  • 晚期诊断与全因死亡风险升高相关(HR 4.68)。
  • 早期OPT与延迟RAA或死亡无显著关联。

核心结论

  • 马凡综合征晚期诊断与延迟升主动脉置换和心血管死亡相关。

研究设计与样本

  • 回顾性观察性队列研究,纳入288例马凡综合征且携带致病性FBN1变异、定期就诊于欧洲参考网络中心的连续患者,采用21岁起点的界标设计分析。

主要发现

  • 平均随访25±14.7年,78例患者发生延迟RAA(42例因急性A型主动脉夹层手术,36例因动脉瘤直径≥5.0 cm手术),33例死亡且均为心血管死亡。
  • 晚期诊断与延迟RAA单变量相关(P < .001),多变量Cox回归证实为预测因素(HR 8.01;95%CI 2.52-25.45;P < .001)。
  • 晚期诊断与死亡单变量相关(P = .025),多变量Cox回归证实为预测因素(HR 4.68;95%CI 1.17-18.80;P = .029)。
  • 早期OPT与延迟RAA或死亡均无显著关联。

关键数值与推荐

  • 马凡综合征指南推荐最佳药物治疗(OPT)及升主动脉直径达5.0 cm时行升主动脉置换(RAA),以预防急性A型主动脉夹层和死亡。
  • 本研究将MFS诊断年龄≥21岁定义为晚期,OPT起始年龄<21岁定义为早期。

临床怎么用

  • 对于马凡综合征患者,晚期诊断(≥21岁)提示延迟RAA和心血管死亡风险较高。
  • 早期OPT未显示与延迟RAA或死亡的显著关联。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Marfan syndrome (MFS) guidelines recommend optimal pharmacologic therapy (OPT) and replacement of the ascending aorta (RAA) at 5.0 cm in diameter to prevent acute type A aortic dissection (ATAAD) and death. The effect of early MFS diagnosis and initiation of therapy on outcomes is not known. Therefore, we sought to evaluate the effect of age at MFS diagnosis and therapy initiation on delayed RAA and death. METHODS: This retrospective observational cohort study with long-term follow-up included consecutive patients with MFS, pathogenic FBN1 variant, and regular visits to a European Reference Network Center. We considered MFS diagnosis at age ≥21 years late and OPT initiation at age <21 years early. Outcomes were delayed RAA with aneurysm diameter >5.0 cm or ATAAD and death from all causes. We used landmark design starting at age 21 years to determine associations with outcomes. RESULTS: The study group consisted of 288 patients (45.1% male), including 169 patients with late diagnosis of MFS (58.7%) and 63 with early OPT (21.9%). During mean follow-up of 25 ± 14.7 years, 78 patients had delayed RAA, with 42 operations for ATAAD and 36 for aneurysms ≥5.0 cm. There were 33 deaths, including 11 deaths late after ATAAD. All deaths were cardiovascular. Late diagnosis, but not early OPT, showed univariate association with delayed RAA (P < .001) and death (P = .025). Multivariate Cox regression analysis confirmed late diagnosis as predictor of delayed RAA (hazard ratio, 8.01; 95% confidence interval, 2.52-25.45; P < .001) and death (hazard ratio, 4.68; 95% confidence interval, 1.17-18.80; P = .029). CONCLUSIONS: Late diagnosis of MFS is associated with delayed surgery and death.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Claus J, Schoof L, Mir TS, et al. Late diagnosis of Marfan syndrome is associated with unplanned aortic surgery and cardiovascular death. J Thorac Cardiovasc Surg. 2024. PMID: 39306029. doi:10.1016/j.jtcvs.2024.09.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。